SA
Sign upLog In

Bio-Rad Laboratories, Inc. Class A Common Stock (BIO)

EBITDA

$542.10M

Quarterly · Period ending: · USD

BIO logo

BIO EBITDA

Latest reported$542.10M
BIO Quarterly EBITDA ($25.40M → $542.10M)
High-resolution chart · PNG

BIO ebitda history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bio-Rad Laboratories, Inc. Class A Common Stock EBITDA — Quarterly (USD)
Period endingEBITDA (USD)
36,644,000
50,927,000
25,784,000
25,940,000
29,287,000
39,753,000
23,200,000
12,800,000
18,094,000
21,938,000
14,500,000
7,500,000
11,900,000
18,200,000
11,500,000
8,000,000
11,900,000
14,900,000
14,700,000
13,200,000
13,900,000
18,100,000
14,100,000
12,100,000
13,200,000
16,900,000
13,500,000
11,400,000
13,000,000
15,600,000
5,100,000
6,200,000
7,100,000
8,500,000
8,400,000
7,000,000
0
13,100,000
7,500,000
8,200,000
7,600,000
10,900,000
10,900,000
6,800,000
7,600,000
9,400,000
6,700,000
5,800,000
7,800,000
56,300,000
-125,800,000
46,200,000
49,000,000
50,500,000
-99,000,000
39,000,000
38,900,000
37,500,000
-80,700,000
31,100,000
31,400,000
30,000,000
-66,400,000
25,400,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.